Fiera Capital (Canada)’s Moderna MRNA Stock Holding History

Fiera Capital (Canada)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,750	Closed	-$241K	–	638
2020 Q2	$241K	Buy	+3,750	New	+$205K	﹤0.01%	578

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fiera Capital (Canada)'s MRNA Position: Q3 2020 in Review

Fiera Capital (Canada) sold out of Moderna (MRNA) in Q3 2020, closing a stake of 3,750 shares — an estimated $241K sold.

Fiera Capital (Canada) first reported a position in MRNA in Q2 2020 and held it in 1 quarter. The position peaked at $241K in Q2 2020. 547 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

Fiera Capital (Canada) reported no remaining Moderna position as of Q3 2020 after selling out during the quarter.
Fiera Capital (Canada) sold 3,750 Moderna shares in Q3 2020, an estimated $241K.
Fiera Capital (Canada) first reported a position in Moderna in Q2 2020 and held it in 1 quarter.
Fiera Capital (Canada)'s Moderna position peaked at $241K in Q2 2020.
547 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2020, filed 12 Nov 2020.